SMTL ID : 3vjo.1

Crystal structure of the wild-type EGFR kinase domain in complex with AMPPNP.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.64 Å

Oligo State

homo-dimer

Ligands

2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.1: 11 residues within 4Å: Chain A: L.30, F.35, A.55, K.57, T.102, Q.103, L.104, M.105, C.109, L.156, D.167 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:T.102, A:Q.103, A:M.105, A:C.109, A:D.167, A:D.167 Salt bridges: A:K.57 ANP.2: 11 residues within 4Å: Chain B: L.30, F.35, A.55, K.57, T.102, Q.103, L.104, M.105, C.109, L.156, D.167 7 PLIP interactions: 7 interactions with chain B Hydrogen bonds: B:T.102, B:Q.103, B:M.105, B:C.109, B:D.167, B:D.167 Salt bridges: B:K.57

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yoshikawa, S. et al., Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor. Oncogene (2013)

Release Date

2012-03-07

Peptides

Epidermal growth factor receptor: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Epidermal growth factor receptor